ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 764043 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 764043; 2) Community: the network communities that were significantly associated with the response to NSC 764043; 3) Molecule: the relationships between components within communities and NSC 764043; 4) MDR: the compounds that were significantly associated with the NSC 764043.

NSC Compound Enrichment Correlation
NSC 672215 Null 0.0293341670043648 0.16096547
NSC 675000 Null 0.0293341670043648 0.12796691
NSC 677598 Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer 0.0293341670043648 -0.13903923
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0293341670043648 0.15288351
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0293341670043648 0.23974376
NSC 681645 Camptothecin Derivative 0.0293341670043648 0.2018993
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0293341670043648 0.15976003
NSC 683558 Camptothecin Derivative 0.0293341670043648 0.13377131
NSC 686940 Null 0.0293341670043648 0.24632031
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0293341670043648 -0.085017683
Total:78  Current:52    [First] [Prev] [Next] [Last]